Provided by Tiger Trade Technology Pte. Ltd.

Fidelity MSCI Health Care Index ETF

81.50
+0.20000.25%
Volume:23.41K
Turnover:1.91M
Market Cap:3.55B
PE:- -
High:81.67
Open:81.51
Low:81.41
Close:81.30
52wk High:85.46
52wk Low:64.30
Shares:43.50M
Float Shares:43.50M
Volume Ratio:0.29
T/O Rate:0.05%
Dividend:1.02
Dividend Rate:1.25%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Abbvie Exec Says Tavapadon U.S. Launch Expected to Have 'Slower Burn' Due to Timing of Medicare Reimbursement - Conf Call

THOMSON REUTERS
·
Yesterday

Why One of the Last Eli Lilly Holdouts Just Upgraded the Stock to Buy

Dow Jones
·
Yesterday

Dow's Nearly 300-Point Fall Led by Losses in Johnson & Johnson, Nike Stocks

Dow Jones
·
Yesterday

U.S. Stocks on the MOVE-Eli Lilly, Waystar, Sysco

Reuters
·
Yesterday

Johnson & Johnson Says Subcutaneous Cancer Treatment Study Shows Low Rates Across Key Events, Discontinuation

MT Newswires Live
·
Yesterday

Testosterone Scripts for Women Rise, Along with Denials and Delays

Reuters
·
Yesterday

Berenberg Upgrades Eli Lilly and Co. to Buy From Hold, Adjusts Price Target to $1,400 From $1,220

MT Newswires Live
·
Yesterday

Lilly Gains After Berenberg Upgrades to 'buy' on Obesity Pill Momentum

Reuters
·
Yesterday

Eli Lilly : Berenberg Raises to Buy from Hold; Raises Target Price to $1,400 from $1,220

THOMSON REUTERS
·
Yesterday

Actinogen Medical Seeks ASX Quotation for 21.9 Million New Shares

TIPRANKS
·
Yesterday

JNJ Reports Low Rates of Treatment-Related Events for Rybrevant Faspro Plus Lazcluze at Wclc 2026

Reuters
·
Yesterday

J&J - Fewer than 1% Discontinue Rybrevant Faspro Plus Lazcluze Due to Treatment-Related Events at One Year

THOMSON REUTERS
·
Yesterday

Prescient Therapeutics Extends Securities Purchase Plan Deadline

TIPRANKS
·
Yesterday

RBC Capital Sticks to Their Hold Rating for Merck & Company (MRK)

TIPRANKS
·
Yesterday

RBC Capital Sticks to Their Buy Rating for Eli Lilly & Co (LLY)

TIPRANKS
·
Yesterday

Syntara Sets 2026 AGM Date as It Refocuses on Fibrosis and Cancer Pipeline

TIPRANKS
·
Yesterday

Contineum Therapeutics Says Phase 2 Major Depressive Disorder Study Fails to Meet Primary Efficacy Endpoint

MT Newswires Live
·
Yesterday

Medtronic PLC Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Yesterday

Niki BioSolutions Highlights Strategic Synergies in Alzheimer’s Diagnostics

TIPRANKS
·
Yesterday

Contineum Therapeutics Shares Fall After Drug Trial Missed Primary Endpoint

Dow Jones
·
Yesterday